Management of acute coronary syndrome in patients with suspected or confirmed coronavirus disease 2019: Consensus from Taiwan Society of Cardiology

J Formos Med Assoc. 2021 Jan;120(1 Pt 1):78-82. doi: 10.1016/j.jfma.2020.07.017. Epub 2020 Jul 13.

Abstract

Coronavirus disease 2019 (COVID-19) is a highly contagious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Infection with SARS-CoV may cause coronary plaque instability and lead to acute coronary syndrome (ACS). Management of ACS in patients with COVID-19 needs more consideration of the balance between clinical benefit and transmission risk of virus. This review provides recommendations of management strategies for ACS in patients with suspected or confirmed COVID-19 in Taiwan.

Keywords: Acute coronary syndrome; Acute myocardial infarction; Coronavirus disease 2019; Non ST-Segment elevation acute coronary syndrome; ST-Segment elevation myocardial infarction.

Publication types

  • Review

MeSH terms

  • Acute Coronary Syndrome* / epidemiology
  • Acute Coronary Syndrome* / therapy
  • COVID-19* / epidemiology
  • COVID-19* / prevention & control
  • Cardiology / methods
  • Cardiology / standards
  • Comorbidity
  • Consensus
  • Disease Transmission, Infectious / prevention & control*
  • Humans
  • Myocardial Infarction* / epidemiology
  • Myocardial Infarction* / therapy
  • Patient Care Management / methods
  • Risk Assessment
  • SARS-CoV-2 / isolation & purification
  • Societies, Medical / standards
  • Taiwan